NO834627L - Vaeskeholdig puteelement for medisinske anvendelser - Google Patents
Vaeskeholdig puteelement for medisinske anvendelserInfo
- Publication number
- NO834627L NO834627L NO834627A NO834627A NO834627L NO 834627 L NO834627 L NO 834627L NO 834627 A NO834627 A NO 834627A NO 834627 A NO834627 A NO 834627A NO 834627 L NO834627 L NO 834627L
- Authority
- NO
- Norway
- Prior art keywords
- membrane
- liquid
- cellulose
- physiologically acceptable
- acceptable liquid
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 65
- 239000001913 cellulose Substances 0.000 claims abstract description 43
- 229920002678 cellulose Polymers 0.000 claims abstract description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 238000012258 culturing Methods 0.000 claims abstract 2
- 239000012528 membrane Substances 0.000 claims description 63
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 235000015097 nutrients Nutrition 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 238000007789 sealing Methods 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 235000019271 petrolatum Nutrition 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 230000000813 microbial effect Effects 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 229920006037 cross link polymer Polymers 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 239000001963 growth medium Substances 0.000 abstract description 9
- 235000002837 Acetobacter xylinum Nutrition 0.000 abstract description 7
- 241001136169 Komagataeibacter xylinus Species 0.000 abstract 1
- 239000000463 material Substances 0.000 description 82
- 208000027418 Wounds and injury Diseases 0.000 description 43
- 206010052428 Wound Diseases 0.000 description 42
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- 241000894006 Bacteria Species 0.000 description 25
- 239000002609 medium Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 244000235858 Acetobacter xylinum Species 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000002250 absorbent Substances 0.000 description 5
- 230000002745 absorbent Effects 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- -1 polyethylene Polymers 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 210000000416 exudates and transudate Anatomy 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 229960003600 silver sulfadiazine Drugs 0.000 description 4
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940127089 cytotoxic agent Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 239000012779 reinforcing material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 229920002749 Bacterial cellulose Polymers 0.000 description 2
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000005016 bacterial cellulose Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940044683 chemotherapy drug Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000001724 microfibril Anatomy 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000010388 wound contraction Effects 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ZXSGQNYQJIUMQN-UHFFFAOYSA-N 3-(2-methylpiperidin-1-ium-1-yl)propyl benzoate;chloride Chemical compound Cl.CC1CCCCN1CCCOC(=O)C1=CC=CC=C1 ZXSGQNYQJIUMQN-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101100462495 Caenorhabditis elegans rsa-1 gene Proteins 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Hydrocortisone Natural products O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- TYMRLRRVMHJFTF-UHFFFAOYSA-N Mafenide Chemical compound NCC1=CC=C(S(N)(=O)=O)C=C1 TYMRLRRVMHJFTF-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 229920001340 Microbial cellulose Polymers 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004104 Oleandomycin Substances 0.000 description 1
- RZPAKFUAFGMUPI-UHFFFAOYSA-N Oleandomycin Natural products O1C(C)C(O)C(OC)CC1OC1C(C)C(=O)OC(C)C(C)C(O)C(C)C(=O)C2(OC2)CC(C)C(OC2C(C(CC(C)O2)N(C)C)O)C1C RZPAKFUAFGMUPI-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- RWUKNUAHIRIZJG-AFEZEDKISA-M benzyl-dimethyl-[(z)-octadec-9-enyl]azanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)CC1=CC=CC=C1 RWUKNUAHIRIZJG-AFEZEDKISA-M 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960004008 butamben picrate Drugs 0.000 description 1
- ATAGSVCDFKGYPE-UHFFFAOYSA-N butamben picrate Chemical compound CCCCOC(=O)C1=CC=C(N)C=C1.CCCCOC(=O)C1=CC=C(N)C=C1.OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O ATAGSVCDFKGYPE-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000002561 chemical irritant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229940001501 fibrinolysin Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- RZPAKFUAFGMUPI-KGIGTXTPSA-N oleandomycin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C RZPAKFUAFGMUPI-KGIGTXTPSA-N 0.000 description 1
- 235000019367 oleandomycin Nutrition 0.000 description 1
- 229960002351 oleandomycin Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
- 229960004880 tolnaftate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- RXXROIWDLGTUIN-UHFFFAOYSA-N zinc;(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide Chemical compound [Zn+2].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1.C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 RXXROIWDLGTUIN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/450,324 US4588400A (en) | 1982-12-16 | 1982-12-16 | Liquid loaded pad for medical applications |
Publications (1)
Publication Number | Publication Date |
---|---|
NO834627L true NO834627L (no) | 1984-06-18 |
Family
ID=23787642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO834627A NO834627L (no) | 1982-12-16 | 1983-12-15 | Vaeskeholdig puteelement for medisinske anvendelser |
Country Status (16)
Country | Link |
---|---|
US (1) | US4588400A (fi) |
EP (1) | EP0114481B1 (fi) |
JP (1) | JPS59120159A (fi) |
AT (1) | ATE26217T1 (fi) |
AU (1) | AU565483B2 (fi) |
CA (1) | CA1207263A (fi) |
DE (1) | DE3370588D1 (fi) |
DK (1) | DK579683A (fi) |
FI (1) | FI77783C (fi) |
GB (1) | GB2131701B (fi) |
HK (1) | HK63286A (fi) |
IE (1) | IE54829B1 (fi) |
MX (1) | MX159720A (fi) |
MY (1) | MY8700121A (fi) |
NO (1) | NO834627L (fi) |
NZ (1) | NZ206488A (fi) |
Families Citing this family (159)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4655758A (en) * | 1982-12-16 | 1987-04-07 | Johnson & Johnson Products, Inc. | Microbial polysaccharide articles and methods of production |
BR8404937A (pt) * | 1984-10-01 | 1986-05-06 | Bio Fill Ind E Comercio De Pro | Processo para preparacao de pelicula de celulose,pelicula de celulose obtida pelo mesmo,implante de pele artificial,processo de tratamento de lesoes empregando a referida pelicula de celulose e utilizacao |
JPS61113601A (ja) * | 1984-11-07 | 1986-05-31 | Ajinomoto Co Inc | セルロース性離解物及びその製造法 |
JPH0832798B2 (ja) * | 1985-04-16 | 1996-03-29 | 工業技術院長 | バクテリアセルロ−ス含有高力学強度成形材料 |
EP0200409B1 (en) * | 1985-04-16 | 1994-06-29 | Agency Of Industrial Science And Technology | Moulded material comprising bacteria-produced cellulose |
US5079162A (en) * | 1986-08-28 | 1992-01-07 | Weyerhaeuser Company | Reticulated cellulose and methods and microorganisms for the production thereof |
CA1335266C (en) * | 1985-10-18 | 1995-04-18 | Arie Ben-Bassat | Reticulated cellulose product, sheets formed therefrom, methods and microorganisms for the production thereof |
US4863565A (en) * | 1985-10-18 | 1989-09-05 | Weyerhaeuser Company | Sheeted products formed from reticulated microbial cellulose |
US5871978A (en) * | 1985-10-18 | 1999-02-16 | Monsanto Life Sciences Co | Method of producing reticulated cellulose having type II crystalline cellulose |
US5821109A (en) * | 1985-10-18 | 1998-10-13 | Monsanto Life Sciences Co. | Reticulated cellulose and methods and microorganisms for the production thereof |
US5144021A (en) | 1985-10-18 | 1992-09-01 | Weyerhaeuser Company | Reticulated cellulose and methods and microorganisms for the production thereof |
US4919753A (en) * | 1986-04-10 | 1990-04-24 | Weyerhaeuser Company | Nonwoven fabric-like product using a bacterial cellulose binder and method for its preparation |
JP2606213B2 (ja) * | 1986-04-22 | 1997-04-30 | 味の素株式会社 | 修飾された微生物産生セルロースのゲルおよび動物細胞膜との複合体 |
US4646730A (en) * | 1986-05-23 | 1987-03-03 | Johnson & Johnson Products, Inc. | Color stabilized hydrogel dressing and process |
JPS62299208A (ja) * | 1986-06-20 | 1987-12-26 | ポーラ化成工業株式会社 | 化粧用パツド |
US4728323A (en) * | 1986-07-24 | 1988-03-01 | Minnesota Mining And Manufacturing Company | Antimicrobial wound dressings |
EP0260093A3 (en) * | 1986-09-08 | 1988-12-28 | Board Of Regents, The University Of Texas System | Methods for production of cellulose i involving in vitro synthesis |
GB8701396D0 (en) * | 1987-01-22 | 1987-02-25 | Ici Plc | Production of microbial cellulose |
GB8705985D0 (en) * | 1987-03-13 | 1987-04-15 | Geistlich Soehne Ag | Dressings |
US5384125A (en) * | 1987-03-31 | 1995-01-24 | Water-Jel Technologies, Inc. | Burn dressing |
GB8709498D0 (en) * | 1987-04-22 | 1987-05-28 | Bay M | Wound dressing |
ATE99750T1 (de) * | 1987-07-24 | 1994-01-15 | Weyerhaeuser Co | Nichtgewebte gewebeaehnliche erzeugnisse unter verwendung eines bakteriellen zellulosebindemittels und verfahren zur herstellung. |
US5306289A (en) * | 1987-08-26 | 1994-04-26 | United States Surgical Corporation | Braided suture of improved characteristics |
US5366081A (en) | 1987-08-26 | 1994-11-22 | United States Surgical Corporation | Packaged synthetic absorbable surgical elements |
US5222978A (en) | 1987-08-26 | 1993-06-29 | United States Surgical Corporation | Packaged synthetic absorbable surgical elements |
US5037429A (en) * | 1987-08-26 | 1991-08-06 | United States Surgical Corporation | Method for improving the storage stability of a polymeric braided suture susceptible to hydrolytic degradation and resulting article |
US5226912A (en) | 1987-08-26 | 1993-07-13 | United States Surgical Corporation | Combined surgical needle-braided suture device |
US4891313A (en) * | 1988-01-21 | 1990-01-02 | Boehringer Manheim Corporation | Method for determination of a component of a sample |
US4913957A (en) * | 1988-05-23 | 1990-04-03 | Kimberly-Clark Corporation | Thermal retaining fabric laminate |
KR900701327A (ko) * | 1988-05-30 | 1990-12-01 | 원본미기재 | 상처 및 피부손상용 피복치료제와 그 제조방법(Therapeutic material for covering wounds and skin lessions and process for the preparation thereof) |
DE3903672C1 (fi) * | 1989-02-08 | 1990-02-01 | Lohmann Gmbh & Co Kg | |
EP0396344A3 (en) * | 1989-04-28 | 1991-04-03 | Ajinomoto Co., Inc. | Hollow microbial cellulose, process for preparation thereof, and artificial blood vessel formed of said cellulose |
JP2853165B2 (ja) * | 1989-05-29 | 1999-02-03 | 味の素株式会社 | 体組織癒着防止膜 |
US5359831A (en) | 1989-08-01 | 1994-11-01 | United States Surgical Corporation | Molded suture retainer |
US5246104A (en) * | 1989-08-01 | 1993-09-21 | United States Surgical Corporation | Molded suture retainer |
JP2762632B2 (ja) * | 1989-11-27 | 1998-06-04 | 味の素株式会社 | 生体組織代替材 |
US5144957A (en) * | 1990-01-24 | 1992-09-08 | Zetachron | Cutaneous therapeutic devices |
WO1991011135A1 (en) * | 1990-01-24 | 1991-08-08 | Zetachron, Inc. | Cutaneous therapeutic devices |
US5662913A (en) * | 1991-04-10 | 1997-09-02 | Capelli; Christopher C. | Antimicrobial compositions useful for medical applications |
EP0580803B1 (en) * | 1991-04-10 | 1999-07-07 | CAPELLI, Christopher C. | Antimicrobial compositions useful for medical applications |
JP3254013B2 (ja) * | 1991-09-10 | 2002-02-04 | ジョンソン・アンド・ジョンソン・メディカル・インコーポレイテッド | 包帯材料およびその製造方法 |
US6319599B1 (en) * | 1992-07-14 | 2001-11-20 | Theresa M. Buckley | Phase change thermal control materials, method and apparatus |
GR1002418B (el) * | 1992-07-29 | 1996-08-21 | Johnson & Johnson Consumer Products Inc. | Βιοεπισυναπτομενες συνθεσεις θεραπειας και μεθοδοι χρησης. |
CA2102064A1 (en) * | 1992-10-30 | 1994-05-01 | Thomas F. Reiner | Hypertonic saline dressing |
US5320531A (en) * | 1993-01-22 | 1994-06-14 | Delizo Madamba Peggy A | Absorbent finger sleeve for use in dentistry or medicine |
US5447531A (en) * | 1993-03-15 | 1995-09-05 | Hot Springs Thermalsoft, Inc. | Therapeutic heat pack |
DE69426230T2 (de) | 1993-03-22 | 2001-03-01 | Minnesota Mining & Mfg | Mit fensterlosem rahmen abgebener verband sowie herstellungsverfahren |
US6685682B1 (en) | 1993-03-22 | 2004-02-03 | 3M Innovative Properties Company | Carrier delivered dressing and method of manufacture |
US5409471A (en) * | 1993-07-06 | 1995-04-25 | Vernay Laboratories, Inc. | Method of lubricating a medical coupling site |
US5580348A (en) * | 1994-05-10 | 1996-12-03 | Kimberly-Clark Corporation | Absorbent structure comprising a microbial polysaccharide and a process of making the same |
US5810755A (en) * | 1994-10-17 | 1998-09-22 | Leveen; Harry H. | Medicated wound dressing |
US5505958A (en) * | 1994-10-31 | 1996-04-09 | Algos Pharmaceutical Corporation | Transdermal drug delivery device and method for its manufacture |
US5632731A (en) * | 1994-11-25 | 1997-05-27 | The Kendall Company | Non-adherent wound dressing |
JP2683524B2 (ja) * | 1995-04-24 | 1997-12-03 | 工業技術院長 | 固定化担体 |
US5955326A (en) * | 1995-08-01 | 1999-09-21 | Rensselaer Polytechnic Institute | Production of microbial cellulose using a rotating disk film bioreactor |
US5814094A (en) * | 1996-03-28 | 1998-09-29 | Becker; Robert O. | Iontopheretic system for stimulation of tissue healing and regeneration |
US6861570B1 (en) * | 1997-09-22 | 2005-03-01 | A. Bart Flick | Multilayer conductive appliance having wound healing and analgesic properties |
US7214847B1 (en) * | 1997-09-22 | 2007-05-08 | Argentum Medical, L.L.C. | Multilayer conductive appliance having wound healing and analgesic properties |
US8801681B2 (en) * | 1995-09-05 | 2014-08-12 | Argentum Medical, Llc | Medical device |
US8455710B2 (en) * | 1997-09-22 | 2013-06-04 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
US5730721A (en) * | 1996-01-25 | 1998-03-24 | Vesture Corporation | Medical applicator and method |
US6060289A (en) | 1996-07-26 | 2000-05-09 | Ajinomoto Co., Inc. | Modified bacterial cellulose |
IT1289159B1 (it) * | 1997-01-08 | 1998-09-29 | Yurta S R L | Composizioni farmaceutiche e alimentari a base di batteri del genere acetobacter |
US5961500A (en) * | 1997-01-27 | 1999-10-05 | Weinstein; Robert E. | Prewetted medical wipe with impermeable barrier |
US5901706A (en) * | 1997-06-09 | 1999-05-11 | Kimberly-Clark Worldwide, Inc. | Absorbent surgical drape |
US6043407A (en) * | 1997-07-29 | 2000-03-28 | Warner-Lambert Company | Debridement pad |
US6153210A (en) * | 1997-08-14 | 2000-11-28 | Periodontix, Inc. | Use of locally delivered metal ions for treatment of periodontal disease |
US6638603B1 (en) | 1997-08-15 | 2003-10-28 | Kimberly-Clark Worldwide, Inc. | Screen printed coating on water-sensitive film for water protection |
US7337592B2 (en) * | 1997-11-20 | 2008-03-04 | Aion Co., Ltd. | Porous poly(vinyl acetal) resin body having a high degree of cleanliness, a process of preparing the same, and a method of storing the same |
US5985396A (en) | 1997-11-25 | 1999-11-16 | Kimberly-Clark Worldwide, Inc. | Flushable release liners and methods of making the same |
US5981012A (en) | 1997-11-25 | 1999-11-09 | Kimberly-Clark Worldwide, Inc. | Flushable release liner comprising a release coating on a water-sensitive film |
US6530910B1 (en) | 1997-12-31 | 2003-03-11 | Kimberly-Clark Worldwide, Inc. | Flushable release film with combination wiper |
US6269820B1 (en) | 1998-02-26 | 2001-08-07 | Xomed Surgical Products, Inc. | Method of controlling post-operative leakage associated with tumescent liposuction |
US6423804B1 (en) | 1998-12-31 | 2002-07-23 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive hard water dispersible polymers and applications therefor |
US6579570B1 (en) | 2000-05-04 | 2003-06-17 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6713414B1 (en) | 2000-05-04 | 2004-03-30 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6191334B1 (en) * | 1999-03-03 | 2001-02-20 | Acoustic Technologies Inc. | Perforation repair device and method |
US7063859B1 (en) | 1999-04-28 | 2006-06-20 | Noven Pharmaceuticals, Inc. | Barrier film lined backing layer composition and method for topical administration of active agents |
US6541678B2 (en) * | 1999-09-27 | 2003-04-01 | Brennen Medical, Inc. | Immunostimulating coating for surgical devices |
DE10022751C2 (de) * | 2000-03-10 | 2002-04-18 | Fzmb Forschungszentrum Fuer Me | Verfahren zur Herstellung von spezifischen Formkörpern oder Schichten aus Bakteriencellulose |
US6444214B1 (en) | 2000-05-04 | 2002-09-03 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6815502B1 (en) | 2000-05-04 | 2004-11-09 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersable polymers, a method of making same and items using same |
US6599848B1 (en) | 2000-05-04 | 2003-07-29 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6683143B1 (en) | 2000-05-04 | 2004-01-27 | Kimberly Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6548592B1 (en) | 2000-05-04 | 2003-04-15 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6653406B1 (en) | 2000-05-04 | 2003-11-25 | Kimberly Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6429261B1 (en) | 2000-05-04 | 2002-08-06 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
US6835678B2 (en) | 2000-05-04 | 2004-12-28 | Kimberly-Clark Worldwide, Inc. | Ion sensitive, water-dispersible fabrics, a method of making same and items using same |
KR100405776B1 (ko) * | 2000-05-08 | 2003-11-15 | 주식회사 엔바이오테크놀러지 | 미생물 셀룰로오스를 주성분으로 포함하는 웨트 시이트제조방법 및 그 용도 개발 |
US6369289B1 (en) * | 2000-07-07 | 2002-04-09 | Tyco Healthcare Group Lp | Method and manufacture of a wound dressing for covering an open wound |
US6838399B1 (en) | 2000-12-01 | 2005-01-04 | Kimberly-Clark Worldwide, Inc. | Fibrous layer providing improved porosity control for nonwoven webs |
US6586529B2 (en) | 2001-02-01 | 2003-07-01 | Kimberly-Clark Worldwide, Inc. | Water-dispersible polymers, a method of making same and items using same |
US6828014B2 (en) | 2001-03-22 | 2004-12-07 | Kimberly-Clark Worldwide, Inc. | Water-dispersible, cationic polymers, a method of making same and items using same |
US20030203013A1 (en) * | 2002-04-26 | 2003-10-30 | Xylos Corporation | Microbial cellulose wound dressing for treating chronic wounds |
US20050019380A1 (en) * | 2002-04-26 | 2005-01-27 | Xylos Corporation | Microbial cellulose wound dressing for treating chronic wounds |
US7390499B2 (en) * | 2002-04-26 | 2008-06-24 | Lohmann & Rauscher Gmbh | Microbial cellulose wound dressing for treating chronic wounds |
US7704523B2 (en) * | 2002-04-26 | 2010-04-27 | Lohmann & Rauscher Gmbh | Microbial cellulose wound dressing for treating chronic wounds |
US20030220632A1 (en) * | 2002-05-23 | 2003-11-27 | Wolfgang Strasser | Method of using gel sheets for laser treatment |
US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
US20040142019A1 (en) * | 2003-01-16 | 2004-07-22 | Xylos Corporation | Microbial-derived cellulose amorphous hydrogel wound dressing |
JP2006512981A (ja) * | 2003-01-16 | 2006-04-20 | ザイロス コーポレイション | 微生物由来セルロース無定形ヒドロゲル創傷包帯 |
EP1438975B1 (en) * | 2003-01-16 | 2005-11-16 | Xylos Corporation | Microbial-derived cellulose amorphous hydrogel wound dressing |
US7351217B2 (en) * | 2003-05-23 | 2008-04-01 | Yvette Scherpenborg | Thermal compressive aerating bandage and methods of use relating to same |
US7959592B2 (en) * | 2003-05-23 | 2011-06-14 | Therogel, Inc. | Tubular compressive device and methods of use relating to same |
IL156374A0 (en) * | 2003-06-10 | 2004-01-04 | Danenberg Holdings 2000 Ltd N | Method for removing a pigmented section of skin |
US20050037082A1 (en) * | 2003-08-13 | 2005-02-17 | Wan-Kei Wan | Poly(vinyl alcohol)-bacterial cellulose nanocomposite |
US9206414B2 (en) * | 2003-08-13 | 2015-12-08 | Axcelon Biopolymers Corporation | Anisotropic nanocomposite hydrogel |
IL157696A0 (en) * | 2003-09-01 | 2004-03-28 | Hawk Medical Technologies Ltd | Apparatus and method for removing a pigmented section of skin |
JP2006051295A (ja) * | 2003-09-04 | 2006-02-23 | Sumitomo Rubber Ind Ltd | 枕 |
US20080297878A1 (en) * | 2003-10-01 | 2008-12-04 | Board Of Regents, The University Of Texas System | Compositions, methods and systems for making and using electronic paper |
US20050079386A1 (en) * | 2003-10-01 | 2005-04-14 | Board Of Regents, The University Of Texas System | Compositions, methods and systems for making and using electronic paper |
US7497947B2 (en) * | 2004-04-14 | 2009-03-03 | Embro Corporation | Devices for water treatment |
BRPI0405990B1 (pt) * | 2004-12-22 | 2013-08-13 | processo contÍnuo de fermentaÇço para a produÇço de manta celulàsica bacteriana. | |
US7582067B2 (en) * | 2005-03-15 | 2009-09-01 | Ted Gerard Van Acker | Prepared medication applicator including a swab and a pharmacological active agent |
WO2006102756A1 (en) | 2005-03-30 | 2006-10-05 | University Western Ontario | Anisotropic hydrogels |
US20060240084A1 (en) * | 2005-04-20 | 2006-10-26 | Xylos Corporation | Microbial cellulose materials for use in transdermal drug delivery systems, method of manufacture and use |
JP2008536937A (ja) * | 2005-04-20 | 2008-09-11 | ザイロス コーポレイション | 経皮薬物送達系に用いる微生物セルロース材料、製造および使用方法 |
BRPI0614477A2 (pt) * | 2005-08-01 | 2011-03-29 | Hawk Medical Technologies Ltd | uso de ácido salicìlico para a erradicação de pigmentação em uma área de pele, aparelho para essa erradicação e método de utilização de um aparelho para perfuração da pele |
US8951551B2 (en) * | 2005-08-31 | 2015-02-10 | Board Of Regents, The University Of Texas System | Multiribbon nanocellulose as a matrix for wound healing |
US20070128243A1 (en) | 2005-12-02 | 2007-06-07 | Xylos Corporation | Implantable microbial cellulose materials for various medical applications |
EP1815877B1 (en) * | 2006-02-02 | 2009-11-25 | Euro-Celtique S.A. | Hydrogel for the treatment of wounds |
WO2007091801A1 (en) * | 2006-02-07 | 2007-08-16 | Natural F & P Corp. | A sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem |
US7709631B2 (en) | 2006-03-13 | 2010-05-04 | Xylos Corporation | Oxidized microbial cellulose and use thereof |
CN100367925C (zh) * | 2006-03-29 | 2008-02-13 | 钟春燕 | 细菌纤维素凝胶面膜 |
BRPI0601330A (pt) * | 2006-03-31 | 2007-12-04 | Wellborn Participacoes Societa | composição tópica de biocelulose em forma de gel, spray-aerosol, creme e ou suspensão aquosa para tratamento de lesões epiteliais |
WO2007140573A1 (en) * | 2006-04-24 | 2007-12-13 | Axcelon Biopolymers Corporation | Nanosilver coated bacterial cellulose |
US20070286884A1 (en) * | 2006-06-13 | 2007-12-13 | Xylos Corporation | Implantable microbial cellulose materials for hard tissue repair and regeneration |
ITTO20060932A1 (it) * | 2006-12-29 | 2008-06-30 | Medestea Res & Production S P A | Procedimento per la produzione di una pellicola a base di cellulosa, da utilizzare per la copertura, riparazione, rigenerazione e cicatrizzazione di lesioni cutanee e tissutali e pellicola cosi' ottenuta. |
DE102007029796A1 (de) † | 2007-06-27 | 2009-01-08 | Paul Hartmann Ag | Wundverband |
EP2070557A1 (en) | 2007-12-12 | 2009-06-17 | Xylos Corporation | Implantable microbial cellulose materials for hard tissue repair and regeneration |
US20090209897A1 (en) * | 2008-02-20 | 2009-08-20 | Lotec, Inc. Dba Vesta Sciences, Inc. | Photoactivated Antimicrobial Wound Dressing and Method Relating Thereto |
US7832857B2 (en) * | 2008-08-18 | 2010-11-16 | Levinson Dennis J | Microbial cellulose contact lens |
JP5300053B2 (ja) * | 2008-10-17 | 2013-09-25 | 独立行政法人国立高等専門学校機構 | 不揮発性バクテリアセルロースゲルの製造方法 |
US9107978B2 (en) * | 2008-11-07 | 2015-08-18 | Sofradim Production | Template for bacterial cellulose implant processed within bioreactor |
CA2741519C (en) | 2008-11-07 | 2017-03-21 | Sofradim Production | Composite mesh including a 3d mesh and a non porous film of oxidized cellulose from bacterial cellulose origin |
US20100159046A1 (en) * | 2008-12-19 | 2010-06-24 | Xylos Corporation | Minimal tissue attachment implantable materials |
US20100158985A1 (en) | 2008-12-19 | 2010-06-24 | Xylos Corporation | Porous structures of microbial-derived cellulose for in vivo implantation |
US20110206928A1 (en) * | 2009-08-24 | 2011-08-25 | Maranchi Jeffrey P | Reinforced Fibers and Related Processes |
US8778387B2 (en) * | 2009-09-02 | 2014-07-15 | Hyprotek, Inc. | Antimicrobial medical dressings and protecting wounds and catheter sites |
AT509289B1 (de) * | 2009-12-28 | 2014-06-15 | Chemiefaser Lenzing Ag | Funktionalisierter cellulosischer formkörper und verfahren zu seiner herstellung |
US8772003B2 (en) * | 2010-05-24 | 2014-07-08 | Nympheas International Biomaterial Corp. | Bacterial cellulose film and uses thereof |
CN101869516B (zh) * | 2010-06-07 | 2011-10-26 | 钟春燕 | 一种细菌纤维素冰敷袋及其生产方法 |
DE102010050311A1 (de) * | 2010-11-03 | 2012-05-03 | Bsn Medical Gmbh | Wundauflage mit einer Biocelluloseschicht, die Bakterien adsorbierend ausgerüstet ist |
CA2845931C (en) | 2011-09-07 | 2016-07-12 | Embro Corporation | Use of moss to reduce disinfection by-products in water treated with disinfectants |
EP2771068B1 (en) * | 2011-10-03 | 2021-05-05 | Metuas Medikal Saglik Hizmetleri Danismanlik Ihracat Ithalat Limited Sirketi | Magnetic diffusional patch |
US9039967B2 (en) | 2012-02-06 | 2015-05-26 | Hyprotek, Inc. | Antiseptic applicators and packaging techniques |
US20130267915A1 (en) * | 2012-04-09 | 2013-10-10 | David Hoffman | Medical grade cleansing and numbing agent combination pad |
KR101399646B1 (ko) | 2012-09-12 | 2014-06-02 | 대한민국(농촌진흥청장) | 감귤 유래의 박테리아 셀룰로오스를 주재로 하는 생분해성 및 무독성 필름 타입의 의료용 드레싱 제재 |
US9795809B2 (en) | 2013-12-23 | 2017-10-24 | Embro Corporation | Use of moss to improve dental health |
US10328178B2 (en) | 2014-05-30 | 2019-06-25 | Sofradim Production | Implant comprising oxidized cellulose and method for preparing such an implant |
US10709820B2 (en) | 2014-11-24 | 2020-07-14 | Biotronik Ag | Method for producing a storable molded body made of bacterial cellulose |
US10569071B2 (en) | 2015-08-31 | 2020-02-25 | Ethicon Llc | Medicant eluting adjuncts and methods of using medicant eluting adjuncts |
US10245034B2 (en) * | 2015-08-31 | 2019-04-02 | Ethicon Llc | Inducing tissue adhesions using surgical adjuncts and medicants |
US10617274B2 (en) * | 2015-10-02 | 2020-04-14 | The Procter & Gamble Company | Cleaning pad having correlated cleaning performance |
US20170216486A1 (en) | 2016-01-29 | 2017-08-03 | Genadyne Biotechnologies, Inc. | System and Method for Treating a Wound |
US10773008B2 (en) * | 2016-08-08 | 2020-09-15 | Universiti Brunei Darussalam | Medicated patch for preventing exit site infections during peritoneal dialysis |
EP3572043B1 (en) | 2018-05-23 | 2023-08-16 | Biotronik Ag | Medical implant with seamlessly connected bacterial cellulose |
WO2020040704A1 (en) * | 2018-08-22 | 2020-02-27 | Novamedic Company Limited | Bandage |
US20230172761A1 (en) * | 2021-12-08 | 2023-06-08 | Samuel Messinger | Self-adhesive flexible bandages for joints |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3419006A (en) * | 1966-08-08 | 1968-12-31 | Union Carbide Corp | Novel dressing and use thereof |
US3814095A (en) * | 1972-03-24 | 1974-06-04 | H Lubens | Occlusively applied anesthetic patch |
US3993551A (en) * | 1973-09-10 | 1976-11-23 | Union Carbide Corporation | Process for cocrosslinking water soluble polymers and products thereof |
IN144058B (fi) * | 1974-12-09 | 1978-03-18 | Personal Products Co | |
GB1570487A (en) * | 1975-10-17 | 1980-07-02 | Takeda Chemical Industries Ltd | Mucilaginous polysaccharide ax |
US4289824A (en) * | 1977-04-22 | 1981-09-15 | Avtex Fibers Inc. | High fluid-holding alloy rayon fiber mass |
US4307717A (en) * | 1977-11-07 | 1981-12-29 | Lectec Corporation | Sterile improved bandage containing a medicament |
US4320198A (en) * | 1979-08-08 | 1982-03-16 | Mynatt Roy L | Fiber production from continuous cultivation of micro-organisms |
DE2946553A1 (de) * | 1979-11-17 | 1981-05-27 | Hoechst Ag, 6000 Frankfurt | Abdeckvorrichtung zur behandlung der haut auf basis von gelartigen polymeren |
US4378431A (en) * | 1980-09-02 | 1983-03-29 | The University Of N.C. At Chapel Hill | Production of a cellulose-synthetic polymer composite fiber |
US4346709A (en) * | 1980-11-10 | 1982-08-31 | Alza Corporation | Drug delivery devices comprising erodible polymer and erosion rate modifier |
US4373519A (en) * | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4423101A (en) * | 1981-10-13 | 1983-12-27 | Johnson & Johnson | Absorbent products |
-
1982
- 1982-12-16 US US06/450,324 patent/US4588400A/en not_active Expired - Lifetime
-
1983
- 1983-12-05 NZ NZ206488A patent/NZ206488A/en unknown
- 1983-12-14 CA CA000443260A patent/CA1207263A/en not_active Expired
- 1983-12-15 JP JP58235240A patent/JPS59120159A/ja active Pending
- 1983-12-15 DK DK579683A patent/DK579683A/da not_active Application Discontinuation
- 1983-12-15 DE DE8383307636T patent/DE3370588D1/de not_active Expired
- 1983-12-15 EP EP83307636A patent/EP0114481B1/en not_active Expired
- 1983-12-15 NO NO834627A patent/NO834627L/no unknown
- 1983-12-15 IE IE2964/83A patent/IE54829B1/en unknown
- 1983-12-15 GB GB08333461A patent/GB2131701B/en not_active Expired
- 1983-12-15 AT AT83307636T patent/ATE26217T1/de not_active IP Right Cessation
- 1983-12-15 MX MX199777A patent/MX159720A/es unknown
- 1983-12-15 FI FI834623A patent/FI77783C/fi not_active IP Right Cessation
- 1983-12-16 AU AU22490/83A patent/AU565483B2/en not_active Ceased
-
1986
- 1986-08-28 HK HK632/86A patent/HK63286A/xx not_active IP Right Cessation
-
1987
- 1987-12-30 MY MY121/87A patent/MY8700121A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB2131701B (en) | 1986-03-12 |
EP0114481B1 (en) | 1987-04-01 |
FI77783C (fi) | 1989-05-10 |
AU565483B2 (en) | 1987-09-17 |
CA1207263A (en) | 1986-07-08 |
ATE26217T1 (de) | 1987-04-15 |
FI77783B (fi) | 1989-01-31 |
US4588400A (en) | 1986-05-13 |
IE54829B1 (en) | 1990-02-14 |
AU2249083A (en) | 1984-06-21 |
MY8700121A (en) | 1987-12-31 |
FI834623A0 (fi) | 1983-12-15 |
HK63286A (en) | 1986-09-05 |
JPS59120159A (ja) | 1984-07-11 |
NZ206488A (en) | 1986-04-11 |
DK579683D0 (da) | 1983-12-15 |
DE3370588D1 (en) | 1987-05-07 |
MX159720A (es) | 1989-08-09 |
GB2131701A (en) | 1984-06-27 |
DK579683A (da) | 1984-06-17 |
GB8333461D0 (en) | 1984-01-25 |
IE832964L (en) | 1984-06-16 |
FI834623A (fi) | 1984-06-17 |
EP0114481A1 (en) | 1984-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO834627L (no) | Vaeskeholdig puteelement for medisinske anvendelser | |
US4788146A (en) | Liquid loaded pad for medical applications | |
US4655758A (en) | Microbial polysaccharide articles and methods of production | |
US7709021B2 (en) | Microbial cellulose wound dressing for treating chronic wounds | |
US7704523B2 (en) | Microbial cellulose wound dressing for treating chronic wounds | |
RU2437681C1 (ru) | Раневое покрытие с лечебным действием | |
CN106344954A (zh) | 一种生物抗菌细菌纤维素敷料及其制备方法 | |
JP4486304B2 (ja) | 慢性創傷の治療用の微生物セルロース性創傷被覆材 | |
CA2411240A1 (en) | Wound dressing | |
KR100372560B1 (ko) | 숯 충진 수화겔 드레싱 및 방사선을 이용한 그의 제조방법 | |
CA1295327C (en) | Pliant, water-absorbent, laminar mass of microbial cellulose | |
WO2001092382A1 (en) | Films and uses thereof | |
BRPI0000465B1 (pt) | processo a obtenção de membranas celulósicas porosas e/ou fenestradas para o tratamento de feridas |